7.5

CVE-2023-30995: IBM Aspera Faspex improper access control

Modified
Published 08-09-2023Last modified 26-09-2024

Vulnerability summary

CVE-2023-30995 is a high (CVSS 7.5) Incorrect Authorization vulnerability in ibm aspera_faspex. EPSS estimates a 0.91% chance of exploitation in the next 30 days, higher than 60.2% of scored vulnerabilities.

Priority
Prioritisesevere

Severe, CVSS 7.5 (CVE.org); no exploitation reported by the 5 checked sources; EPSS 1% (FIRST, 10-11-2026)

Source freshness unavailable

How is this decided?
CVSS score
7.5/10
010
High · v3.1 (CVE.org)
EPSS score
0.91%
0%100%
Low · 0.00 pp in 30 days
KEVNot listedNot listed by any tracked catalog.
RansomwareNot flaggedNo ransomware use recorded.
Public exploits0No public exploits recorded

Timeline

  1. 08-09-2023
    PublishedVulnerability first disclosed.
  2. 26-09-2024
    Last modifiedVulnerability information updated.

Description

IBM Aspera Faspex 4.0 through 4.4.2 and 5.0 through 5.0.5 could allow a malicious actor to bypass IP whitelist restrictions using a specially crafted HTTP request. IBM X-Force ID: 254268.

CVSS metrics

2 scores · 2 sources · 1 version

EPSS trend

Probability

0.91%

Chance of exploitation in the next 30 days

Percentile

60%

Versus all other CVEs

30-day change

No change 0.00 pp

From 0.91% on 11-10-2026

11-10-202610-11-2026

Known exploited

Compare KEV catalogs
CISA KEV

Not in the CISA KEV catalog.

ENISA CNW

Not in the ENISA CNW catalog.

CIRCL

Not in the CIRCL catalog.

Public exploits

0 found

No public exploits indexed.

Weaknesses

CWE · root cause

Affected systems

Version check

Known conditions: network-reachable, no authentication, no user interaction (CVSS vector). Other conditions: not stated in public data.

Ibm1 product

1 vendor · 1 product

References

3 links